Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancer

  • A Janssen
  • , CPM Verkleij
  • , A van der Vlist
  • , Ron Mathijssen
  • , HJ Bloemendal
  • , R ter Heine

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
39 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1312-1317
Number of pages6
JournalBritish Journal of Cancer
Volume116
Issue number10
DOIs
Publication statusPublished - 2017

Research programs

  • EMC MM-03-86-08

Cite this